Acetylcholine receptors (muscarinic) in GtoPdb v.2025.3
N.J.M. Birdsall(The Francis Crick Institute), Jürgen Wess(National Institute of Diabetes and Digestive and Kidney Diseases), Neil M. Nathanson(University of Washington), Christian C. Felder(National Institutes of Health), Arthur Christopoulos(Australian Research Council), Céline Valant(Monash University), Frederick J. Ehlert(University of California, Irvine), David A. Brown(University College London), Noel J. Buckley(King's College London), Andrew B. Tobin(University of Glasgow), Christopher J. Langmead(Australian Regenerative Medicine Institute), R. A. John Challiss(University of Leicester), E. Mutschler(Goethe University Frankfurt), Rudolf Hammer(Bionomics (Australia)), Sophie J. Bradley(University of Glasgow), Roy D. Schwarz, Richard M. Eglen(PerkinElmer (United States)), Günter Lambrecht(Goethe University Frankfurt), David M. Thal(Australian Research Council), F. Mitchelson(The University of Melbourne), H. Kilbinger(Johannes Gutenberg University Mainz)
Cited by 0
Related Papers
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
|Pharmacological Reviews|1998|1.5k
Muscarinic Receptor Subtypes
|The Annual Review of Pharmacology and Toxicology|1990|1.3k
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
The Binding of Agonists to Brain Muscarinic Receptors
|Molecular Pharmacology|1978|676